# Study of Cetuximab to Treat Gastric Cancer

> **NCT00699881** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 61 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** cetuximab

## Key facts

- **NCT ID:** NCT00699881
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2009-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00699881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00699881, "Study of Cetuximab to Treat Gastric Cancer". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00699881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*